Abstract
PD-011 - SAPPHIRE: A randomized phase II study of oxaliplatin discontinuation after 6 cycles of mFOLFOX6 + panitumumab therapy in patients with colorectal cancer: Final analysis of efficacy and safety results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have